Home・Lista de Ações・Ocugen Inc

Ocugen Inc

Fechado

1.66 11.41

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

1.51

Máximo

1.67

Indicadores-chave
By Trading Economics
Rendimento	-1.5M -19M
Vendas	1.7M 1.5M
EPS	-0.06
Margem de lucro	-1,250.946
Funcionários	116
EBITDA	-987K -17M

Recomendações
By TipRanks
Recomendações	Compra Forte
Previsão para 12 meses	+544.67% upside

Dividendos
By Acuity
Próximos Ganhos	31 de jul. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	-190M 437M
Abertura anterior	-9.75
Fecho anterior	1.66

Ocugen Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

28 de jun. de 2026, 23:51 UTC

Bitcoin dips while Ethereum rises amid investor caution over stock market leverage and upcoming AI earnings reports.

28 de jun. de 2026, 23:51 UTC

Japan's retail sales data reveals consumer spending trends amid rising concerns over stock market leverage and volatility, as investors brace for upcoming U.S. Non-Farm Payrolls report.

28 de jun. de 2026, 23:51 UTC

Bitcoin dips while Ethereum rises amid investor concerns over high leverage and volatility in equity markets, with key U.S. economic data expected to influence market dynamics.

28 de jun. de 2026, 23:51 UTC

Bitcoin dips as Ethereum rises amid concerns over high leverage in stock markets and anticipation of Meta's earnings report, with key economic data releases on July 2 expected to impact Federal Reserve policy.

28 de jun. de 2026, 23:51 UTC

ECB Forum on Central Banking Set for June 29, 2026: Focus on Monetary Policy and Interest Rates Amid Economic Uncertainties.

28 de jun. de 2026, 23:51 UTC

Macro News

Bitcoin is lower as geopolitical tensions rise and South Korean stocks decline. It is currently about 5.32% below its 20-day moving average.

28 de jun. de 2026, 23:41 UTC

Japan's Retail Sales Expected to Rise 3.2% in May, Boosting Investor Confidence Amid Global Market Concerns

28 de jun. de 2026, 23:41 UTC

Avalanche is higher today, continuing its modest gain since Saturday's close. The price has fluctuated within a narrow range during the session.

28 de jun. de 2026, 23:41 UTC

The FTSE 100 Index is lower after market hours, reflecting cautious investor sentiment amid rising concerns over high leverage and increased equity financing costs.

28 de jun. de 2026, 23:32 UTC

Macro News

Correlated Moves

Ethereum is trading lower amid heightened geopolitical tensions and stock market volatility. Earlier in the session, it rebounded from a session high.

28 de jun. de 2026, 23:22 UTC

Market Awaits BoE Governor Bailey's Speech on Interest Rates Amid AI-Driven Financial Stability Concerns.

28 de jun. de 2026, 23:22 UTC

Market Awaits U.S. Average Hourly Earnings Data Amid Wage Legislation Debates and AI Sector Concerns Impacting Federal Reserve Policy.

28 de jun. de 2026, 23:22 UTC

U.S. Labor Force Participation Rate Report Set for July 2, Amid Employee Dissatisfaction and Minimum Wage Legislation Debates

28 de jun. de 2026, 23:22 UTC

Investors Brace for Insights on Interest Rates as BoC Governor Macklem's Speech Approaches Amid Economic Challenges in Canada

28 de jun. de 2026, 23:22 UTC

U.S. Unemployment Rate Expected to Hold Steady at 4.3% Ahead of July 2 Release Amid Employee Dissatisfaction and Potential Minimum Wage Legislation

28 de jun. de 2026, 23:22 UTC

U.S. Non Farm Payrolls Report on July 2 Forecasts 114K Job Additions Amid Cautious Market Sentiment and Legislative Changes Impacting Labor Dynamics.

28 de jun. de 2026, 23:22 UTC

Market Awaits June 2026 Average Hourly Earnings Data Amidst Wage Growth Concerns and Legislative Push for Minimum Wage Increase.

28 de jun. de 2026, 23:12 UTC

Mexico's Consumer Confidence Index set for July 3, 2026 release amid declining sentiment and cautious market expectations.

28 de jun. de 2026, 23:11 UTC

GBP/CHF remains roughly flat during after-market hours, trading within a routine range since Friday's close amid concerns over high leverage in the stock market.

28 de jun. de 2026, 23:11 UTC

SGD/CHF is trading roughly flat in after-market hours, remaining near the upper end of its one-month range amid broader market volatility concerns.

28 de jun. de 2026, 23:11 UTC

Correlated Moves

USD/SEK remains roughly flat in after-market hours amid concerns about high leverage in the stock market and its impact on volatility.

28 de jun. de 2026, 23:11 UTC

Correlated Moves

CHF/HKD trading remains roughly flat during after-market hours amid concerns over high stock market leverage and increased volatility in equity financing costs.

28 de jun. de 2026, 23:01 UTC

Gold and silver prices are trading higher during the ongoing session, remaining above their 20-day moving average and near the upper end of their one-month range.

28 de jun. de 2026, 23:01 UTC

Correlated Moves

Silver/CHF is lower today, following a decline from earlier highs. The asset trades below its 20-day moving average amid shifting market sentiment and increased volatility.

28 de jun. de 2026, 23:01 UTC

Correlated Moves

Silver/GBP is lower today, reflecting declines in correlated assets like gold. Prices have fluctuated notably, currently near the lower end of its one-month range.

28 de jun. de 2026, 23:01 UTC

Macro News

US 10Y Treasury Bond Index advances amid escalating Middle East tensions and lower oil prices, reflecting cautious investor sentiment near the upper trading range.

28 de jun. de 2026, 23:01 UTC

The US 5Y Treasury Bond Index is trading higher, reflecting increased activity. It remains near the upper end of its one-month trading range.

28 de jun. de 2026, 23:01 UTC

Macro News

Tensions between the U.S. and Iran have reportedly eased, potentially influencing global oil markets. The US 2Y Treasury Bond Index is trading roughly flat.

28 de jun. de 2026, 23:01 UTC

Correlated Moves

Silver/SGD is trading lower, reflecting a challenging market environment and notable volatility. The asset remains significantly below its 20-day moving average.

28 de jun. de 2026, 23:01 UTC

Correlated Moves

Silver/JPY is lower today, reflecting notable volatility and trading near the lower end of its one-month range. The asset is approximately 9.98% below its 20-day moving average.

Comparação entre Pares

Variação de preço

Ocugen Inc Previsão

Preço-alvo

By TipRanks

544.67% parte superior

Previsão para 12 meses

Média 9.67 USD 544.67%

Máximo 12 USD

Mínimo 7 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Ocugen Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

6 ratings

Comprar

Manter

Vender

Com base em 6 analistas que deram avaliações de ações para Ocugen Inc - Dist nos últimos 3 meses.

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Ocugen Inc

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is also involved in the development of OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage, currently under Phase 3 studies indicated for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.